{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["anaesthesia", "blood pressure", "nitric oxide", "protein kinase C", "single nucleotide polymorphisms"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34825477", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "12", "Day": "07"}], "ELocationID": ["10.1111/bcpt.13691"], "Journal": {"ISSN": "1742-7843", "JournalIssue": {"Volume": "130", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Basic & clinical pharmacology & toxicology", "ISOAbbreviation": "Basic Clin Pharmacol Toxicol"}, "ArticleTitle": "Gene-gene interactions in the protein kinase C/endothelial nitric oxide synthase axis impact the hypotensive effects of propofol.", "Pagination": {"StartPage": "277", "EndPage": "287", "MedlinePgn": "277-287"}, "Abstract": {"AbstractText": ["Anaesthesia with propofol is frequently associated with hypotension, which is at least partially attributable to increased nitric oxide (NO) formation derived from the activation of protein kinase C (PKC)/endothelial NO synthase (NOS3) axis. In this cross-sectional study, we tested whether PRKCA (which encodes PKC\u03b1) polymorphisms, or haplotypes, and interactions among PRKCA and NOS3 polymorphisms affect the hypotensive responses to propofol. We collected venous blood samples from 164 patients before and 10\u2009min after propofol administration. Genotypes were determined by PCR and haplotype frequencies were estimated. Nitrite and NO<sub>x</sub> (nitrites+nitrates) levels were measured by using an ozone-based chemiluminescence assay and the Griess reaction, respectively. We used multifactor dimensionality reduction to test interactions among PRKCA and NOS3 polymorphisms. Propofol promoted enhanced blood pressure-lowering effects and increased nitrite levels in subjects carrying GA\u2009+\u2009AA genotypes for the rs16960228 and TC\u2009+\u2009CC genotypes for the rs1010544 PRKCA polymorphisms, and the CCG haplotype. Moreover, genotypes for the rs1010544 PRKCA polymorphism were associated with higher or lower blood pressure decreases in response to propofol depending on the genotypes for the rs2070744 NOS3 polymorphism. Our findings suggest that PRKCA genotypes and haplotypes impact the hypotensive responses to propofol, possibly by modifying NO bioavailability, and that PRKCA-NOS3 interactions modify the blood pressure-lowering effects of propofol."], "CopyrightInformation": "\u00a9 2021 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society). Published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}, {"Identifier": [], "Affiliation": "Wilf Family Cardiovascular Research Institute, Department of Medicine, Division of Cardiology, Albert Einstein College of Medicine, New York, New York, USA."}], "LastName": "Oliveira-Paula", "ForeName": "Gustavo H", "Initials": "GH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil."}], "LastName": "Pereira", "ForeName": "Daniela A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Pinheiro", "ForeName": "Lucas C", "Initials": "LC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Ferreira", "ForeName": "Graziele C", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomechanics, Medicine and Rehabilitation of the Locomotor System, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Paula-Garcia", "ForeName": "Waynice N", "Initials": "WN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomechanics, Medicine and Rehabilitation of the Locomotor System, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Garcia", "ForeName": "Luis V", "Initials": "LV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychiatric Nursing and Human Sciences, Ribeirao Preto College of Nursing, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Lacchini", "ForeName": "Riccardo", "Initials": "R"}, {"Identifier": ["0000-0002-8331-3525"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil."}], "LastName": "Luizon", "ForeName": "Marcelo R", "Initials": "MR"}, {"Identifier": ["0000-0002-9945-9633"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil."}], "LastName": "Tanus-Santos", "ForeName": "Jose E", "Initials": "JE"}], "GrantList": [{"Agency": "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico", "Country": ""}, {"GrantID": "2014-23946-0", "Agency": "Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de S\u00e3o Paulo", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Basic Clin Pharmacol Toxicol", "NlmUniqueID": "101208422", "ISSNLinking": "1742-7835"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anesthetics, Intravenous"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "NOS3 protein, human"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "PRKCA protein, human"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C-alpha"}, {"RegistryNumber": "YI7VU623SF", "NameOfSubstance": "Propofol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Anesthetics, Intravenous"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": [], "DescriptorName": "Haplotypes"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemically induced", "genetics"], "DescriptorName": "Hypotension"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["genetics"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Propofol"}, {"QualifierName": ["genetics"], "DescriptorName": "Protein Kinase C-alpha"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004;10(29):3639-3649."}, {"Citation": "Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology. 1994;81(4):1005-1043."}, {"Citation": "Ferrier DC, Kiely J, Luxton R. Propofol detection for monitoring of intravenous anaesthesia: a review. J Clin Monit Comput. 2021."}, {"Citation": "Kawasaki S, Kiyohara C, Tokunaga S, Hoka S. Prediction of hemodynamic fluctuations after induction of general anesthesia using propofol in non-cardiac surgery: a retrospective cohort study. BMC Anesthesiol. 2018;18(1):167."}, {"Citation": "Hug CC Jr, McLeskey CH, Nahrwold ML, et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg. 1993;77(4 Suppl):S21-S29."}, {"Citation": "Monk TG, Bronsert MR, Henderson WG, et al. Association between Intraoperative Hypotension and Hypertension and 30-day Postoperative Mortality in Noncardiac Surgery. Anesthesiology. 2015;123(2):307-319."}, {"Citation": "Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121(4):706-721."}, {"Citation": "Gragasin FS, Davidge ST. The effects of propofol on vascular function in mesenteric arteries of the aging rat. Am J Physiol Heart Circ Physiol. 2009;297(1):H466-H474."}, {"Citation": "Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide. 2017;63:39-51."}, {"Citation": "Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms. Gene. 2016;575(2):584-599."}, {"Citation": "Oliveira-Paula GH, Pinheiro LC, Ferreira GC, et al. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production. Free Radic Biol Med. 2018;115:10-17."}, {"Citation": "Oliveira-Paula GH, Coeli-Lacchini FB, Ferezin LP, et al. Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability. Eur J Clin Pharmacol. 2021;77(6):869-877."}, {"Citation": "Kleinbongard P, Dejam A, Lauer T, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med. 2003;35(7):790-796."}, {"Citation": "Kleinbongard P, Dejam A, Lauer T, et al. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med. 2006;40(2):295-302."}, {"Citation": "Wang L, Wu B, Sun Y, et al. Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation. Br J Anaesth. 2010;104(5):606-612."}, {"Citation": "Kanashiro CA, Khalil RA. Signal transduction by protein kinase C in mammalian cells. Clin Exp Pharmacol Physiol. 1998;25(12):974-985."}, {"Citation": "Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258(5082):607-614."}, {"Citation": "Salamanca DA, Khalil RA. Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension. Biochem Pharmacol. 2005;70(11):1537-1547."}, {"Citation": "Partovian C, Zhuang Z, Moodie K, et al. PKCalpha activates eNOS and increases arterial blood flow in vivo. Circ Res. 2005;97(5):482-487."}, {"Citation": "Wang Y, Zhou H, Wu B, Zhou Q, Cui D, Wang L. Protein Kinase C Isoforms Distinctly Regulate Propofol-induced Endothelium-dependent and Endothelium-independent Vasodilation. J Cardiovasc Pharmacol. 2015;66(3):276-284."}, {"Citation": "Miyahara T, Adachi N, Seki T, et al. Propofol induced diverse and subtype-specific translocation of PKC families. J Pharmacol Sci. 2018;137(1):20-29."}, {"Citation": "Kokita N, Hara A, Abiko Y, Arakawa J, Hashizume H, Namiki A. Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth Analg. 1998;86(2):252-258."}, {"Citation": "Ko SH, Yu CW, Lee SK, et al. Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth Analg. 1997;85(4):719-724."}, {"Citation": "Hemmings HC Jr, Adamo AI. Effects of halothane and propofol on purified brain protein kinase C activation. Anesthesiology. 1994;81(1):147-155."}, {"Citation": "Turner ST, Boerwinkle E, O'Connell JR, et al. Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide. Hypertension. 2013;62(2):391-397."}, {"Citation": "Oliveira-Paula GH, Luizon MR, Lacchini R, et al. Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril. Basic Clin Pharmacol Toxicol. 2017;120(3):284-291."}, {"Citation": "Oliveira-Paula GH, Lacchini R, Pinheiro LC, et al. Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol. Nitric Oxide. 2018;75:77-84."}, {"Citation": "Luizon MR, Pereira DA, Sandrim VC. Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions. Front Pharmacol. 2018;9:168."}, {"Citation": "Tveden-Nyborg P, Bergmann TK, Jessen N, Simonsen U, Lykkesfeldt J. BCPT policy for experimental and clinical studies. Basic Clin Pharmacol Toxicol. 2021;128(1):4-8."}, {"Citation": "Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association Studies (STREGA)-an extension of the STROBE statement. Genet Epidemiol. 2009;33(7):581-598."}, {"Citation": "Metzger IF, Sertorio JT, Tanus-Santos JE. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol (Oxf). 2006;188(2):123-127."}, {"Citation": "Silva PS, Fontana V, Palei ACT, Sertorio JTC, Biagi C, Tanus-Santos JE. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. Eur J Clin Pharmacol. 2011;67(4):365-370."}, {"Citation": "Oliveira-Paula GH, Lacchini R, Luizon MR, et al. Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension. Nitric Oxide. 2016;55-56:62-69."}, {"Citation": "Ritchie MD, Motsinger AA. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics. 2005;6(8):823-834."}, {"Citation": "Pander J, Wessels JA, Mathijssen RH, Gelderblom H, Guchelaar HJ. Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle. Pharmacogenomics. 2010;11(7):1011-1017."}, {"Citation": "Luizon MR, Palei ACT, Belo VA, et al. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. Pharmacogenomics J. 2017;17(5):427-434."}, {"Citation": "Woodsome TP, Eto M, Everett A, Brautigan DL, Kitazawa T. Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol. 2001;535(2):553-564."}, {"Citation": "Heitzer T, Wenzel U, Hink U, et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999;55(1):252-260."}, {"Citation": "Motley ED, Eguchi K, Patterson MM, Palmer PD, Suzuki H, Eguchi S. Mechanism of endothelial nitric oxide synthase phosphorylation and activation by thrombin. Hypertension. 2007;49(3):577-583."}, {"Citation": "Li H, Oehrlein SA, Wallerath T, et al. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol. 1998;53(4):630-637."}, {"Citation": "Saarela J, Kallio SP, Chen D, et al. PRKCA and multiple sclerosis: association in two independent populations. PLoS Genet. 2006;2(3):e42."}, {"Citation": "Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med. 2005;56(1):303-320."}, {"Citation": "Oliveira-Paula GH, Lacchini R, Coeli-Lacchini FB, Junior HM, Tanus-Santos JE. Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy. Gene. 2013;515(2):391-395."}, {"Citation": "Miyamoto Y, Saito Y, Nakayama M, et al. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T->C mutation associated with coronary spastic angina. Hum Mol Genet. 2000;9(18):2629-2637."}, {"Citation": "Wang J, Dudley D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002;22(5):e1-e4."}, {"Citation": "Nakayama M, Yasue H, Yoshimura M, et al. T\u2212786\u2192C Mutation in the 5\u2032-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm. Circulation. 1999;99(22):2864-2870."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "10", "Day": "19"}, {"Year": "2021", "Month": "8", "Day": "10"}, {"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "26", "Hour": "7", "Minute": "18"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34825477", "10.1111/bcpt.13691"]}}], "PubmedBookArticle": []}